VJHemOnc is committed to improving our service to you

ESMO 2018 | The CAR-T tsunami: an overview & brief history

VJHemOnc is committed to improving our service to you

Michel Sadelain

Michel Sadelain, MD, PhD, of Memorial Sloan Kettering Cancer Center, New York, NY, provides an overview of chimeric antigen receptor (CAR)-T cell therapy, at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany. Dr Sadelain describes the progress CAR T-cell therapy has made, and suggests that we should aim to improve our current understanding of CAR-T mediated toxicities.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter